CareDx to Announce Third Quarter 2016 Financial Results and Host Conference Call on November 9, 2016
Oct 27, 2016 20:03 pm UTC| Business
BRISBANE, Calif., Oct. 27, 2016 -- CareDx, Inc. (Nasdaq:CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic solutions...
PDF Solutions® Reports Third Fiscal Quarter Results
Oct 27, 2016 20:02 pm UTC| Business
SAN JOSE, Calif., Oct. 27, 2016 -- PDF Solutions, Inc. (“PDF Solutions” or the “Company”) (NASDAQ:PDFS), the leading provider of process-design integration technologies to enhance integrated circuit (IC)...
PDF Solutions® Reports Third Fiscal Quarter Results
Oct 27, 2016 20:02 pm UTC| Business
SAN JOSE, Calif., Oct. 27, 2016 -- PDF Solutions, Inc. (“PDF Solutions” or the “Company”) (NASDAQ:PDFS), the leading provider of process-design integration technologies to enhance integrated circuit (IC)...
Riverview Bancorp Earns $1.7 Million in Second Quarter; Highlighted by Announced Deal with MBank
Oct 27, 2016 20:02 pm UTC| Business
VANCOUVER, Wash., Oct. 27, 2016 -- Riverview Bancorp, Inc. (Nasdaq:RVSB) (“Riverview” or the “Company”) today reported net income of $1.7 million, or $0.07 per diluted share, in the second fiscal quarter ended September...
Oct 27, 2016 20:02 pm UTC| Business
LORIS, S.C., Oct. 27, 2016 -- HCSB Financial Corporation (OTC Pink:HCFB)(the “Company”), the holding company for Horry County State Bank (the “Bank”), announced today that the Bank received notification on October 26,...
Adaptimmune Announces Board Changes
Oct 27, 2016 20:01 pm UTC| Business
PHILADELPHIA and OXFORD, United Kingdom, Oct. 27, 2016 -- Adaptimmune Therapeutics plc (Nasdaq:ADAP) (“Adaptimmune” or the “Company”), a leader in T-cell therapy to treat cancer, today announced changes to its Board of...
Cytokinetics, Inc. Reports Third Quarter 2016 Financial Results
Oct 27, 2016 20:01 pm UTC| Business
Omecamtiv Mecarbil Advancing to Phase 3 With Agreement from FDAon Key Elements of Special Protocol Assessment VIGOR-ALS Enrolling Patients with ALS Who Have Completed VITALITY-ALS $65 Million Recently Received From...